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The DNA damage response (DDR) protein 53BP1
protects DNA ends from excessive resection in G1,
and thereby favors repair by nonhomologous end-
joining (NHEJ) as opposed to homologous recombi-
nation (HR). During S phase, BRCA1 antagonizes
53BP1 to promote HR. The pro-NHEJ and antirecom-
binase functions of 53BP1 are mediated in part
by RIF1, the only known factor that requires 53BP1
phosphorylation for its recruitment to double-strand
breaks (DSBs). Here, we show that a 53BP1
phosphomutant, 53BP18A, comprising alanine sub-
stitutions of the eight most N-terminal S/TQ phos-
phorylation sites, mimics 53BP1 deficiency by
restoring genome stability in BRCA1-deficient cells
yet behaves like wild-type 53BP1 with respect to
immunoglobulin class switch recombination (CSR).
53BP18A recruits RIF1 but fails to recruit the DDR
protein PTIP to DSBs, and disruption of PTIP pheno-
copies 53BP18A. We conclude that 53BP1 promotes
productive CSR and suppresses mutagenic DNA
repair through distinct phosphodependent interac-
tions with RIF1 and PTIP.
INTRODUCTION
Class switch recombination (CSR) is initiated by activation-
induced cytidine deaminase (AID), which generates multiple1266 Cell 153, 1266–1280, June 6, 2013 ª2013 Elsevier Inc.double-strand breaks (DSBs) at highly repetitive immunoglobulin
(Ig) switch regions. Paired distal DSBs are then rejoined by
nonhomologous end-joining (NHEJ), thereby replacing Igm by a
downstream constant region (Igg, Igε, or Iga). Alternatively, if
DSBs persist, a homology-driven pathway that involves resec-
tion of repetitive switch regions, can repair DSBs locally. Such
abortive ‘‘intraswitch’’ recombination events are increased at
the expense of CSR in the absence of 53BP1(Reina-San-Martin
et al., 2007), a key suppressor of end resection (Bothmer et al.,
2010; Bouwman et al., 2010; Bunting et al., 2010; Cao et al.,
2009; Difilippantonio et al., 2008).
In addition to its productive effect on CSR, 53BP1 blocks DNA
ends from resection in BRCA1-deficient cells, leading to toxic
radial chromosomes that arise from NHEJ (Bouwman et al.,
2010; Bunting et al., 2010, 2012; Cao et al., 2009). Deletion of
53BP1 leads to deposition of homologous recombination (HR)
factors RPA and RAD51 on single-strand DNA, which, in the
caseof recombiningswitch regions,promotes intraswitch recom-
bination (Yamane et al., 2013) and, in the setting of BRCA1 defi-
ciency, restores HR (Bouwman et al., 2010; Bunting et al., 2010;
Cao et al., 2009). Thus, DNA end protection by 53BP1 is critical
for CSR in G1 but can unleash genome instability in S phase.
In addition to DNA end-blocking activities that disfavor HR and
thereby promote NHEJ, 53BP1 has been suggested to directly
mediate long-range chromosomal interactions and DSBmobility
that facilitates the juxtaposition of distal DNA ends. These activ-
ities are believed to be responsible for 53BP1’s ability to support
recombination of DSB ends that are far apart during V(D)J
recombination and class switch recombination (Calle´n et al.,
2007b; Difilippantonio et al., 2008) and to fuse uncapped telo-
meric DNA ends (Dimitrova et al., 2008). Both pro-NHEJ and
anti-HR functions require the direct physical association of
53BP1 with DNA ends but also necessitate the DSB-induced
phosphorylation of its N-terminal ATM/ATR kinase sites
(Bothmer et al., 2011; Ward et al., 2006).
The DNA damage response (DDR) protein RIF1 was recently
identified as an essential factor recruited by phosphorylated
53BP1 to promote NHEJ and block HR (Chapman et al., 2013;
Di Virgilio et al., 2013; Escribano-Dı´az et al., 2013; Feng et al.,
2013; Zimmermann et al., 2013). Like 53BP1, RIF1 is required
for CSR (Chapman et al., 2013; Di Virgilio et al., 2013; Escri-
bano-Dı´az et al., 2013). Although the NHEJ of dysfunctional telo-
meres is abrogated in cells lacking 53BP1 or in cells expressing
53BP128A(Lottersberger et al., 2013), an allele harboring alanine
substitutions at all 28 N-terminal ATM/ATR kinase phosphoryla-
tion targets sites, loss of RIF1 has considerably milder defect
(Zimmermann et al., 2013). Moreover, although the generation
of toxic radial chromosomes in BRCA1-deficient cells is pre-
vented in 53BP1/ or in 53BP128A mutant cells (Bothmer
et al., 2011; Bouwman et al., 2010; Bunting et al., 2012; Bunting
et al., 2010), the loss of RIF1 only partially rescues HR in BRCA1-
deficient cells (Escribano-Dı´az et al., 2013; Feng et al., 2013;
Zimmermann et al., 2013). This suggests that additional
phosphorylation-dependent but RIF1-independent activities of
53BP1 might regulate the balance between HR and NHEJ.
PTIP is a ubiquitously expressed nuclear protein that associ-
ates constitutively with two of the known histone methyltrans-
ferases that catalyze trimethylation of histone H3 at lysine 4
(H3K4me3), MLL3, and MLL4 (Cho et al., 2007; Patel et al.,
2007). In addition to its well-established role in transcription initi-
ation, a separate pool of PTIP functions in an unknown capacity
in the DDR (Gong et al., 2009). Indeed, PTIP has been implicated
in both HR (Wang et al., 2010) and NHEJ (Callen et al., 2012).
PTIP is recruited to DSBs by its tandem BRCT (BRCA1
carboxyl-terminal) domains (Manke et al., 2003; Yu et al.,
2003), which associate with the serine 25 phosphorylation site
within the N terminus of 53BP1 (Munoz et al., 2007). In contrast
to RIF1, PTIP recruitment to DSBswas reported to be 53BP1 and
ATM independent (Gong et al., 2009; Jowsey et al., 2004; Munoz
et al., 2007). Thus, the mechanism by which PTIP is recruited to
DSBs, its role in DSB repair, and the physiological significance of
PTIP interaction with 53BP1 remain unclear. Here, we show that
PTIP is required for 53BP1-mediated inhibition of HR in BRCA1-
deficient cells but is dispensable for 53BP1-initiated DSB repair
during productive CSR. Thus, RIF1 and PTIP separate 53BP1
functions in productive and pathologic DSB repair.
RESULTS
A Separation of Function Mutation in 53BP1
To determine whether 53BP1’s activities in NHEJ and HR
are distinct, we compared 53BP18A, which disrupts phosphory-
lation of the eight N-terminal ATM/ATR target sites (Figure 1A),
to the 53BP1DB allele, which is indistinguishable from WT
53BP1 in all functional aspects (Bothmer et al., 2011). To assay
for CSR, BRCA1/53BP1-deficient B cells were transduced with
wild-type and 53BP1 mutant proteins by retroviral infection
after activation with lipopolysaccharide (LPS) and interleukin-4
(IL4). As expected, 53BP1DB fully complemented the CSRdefects (Figure 1B) and produced high levels of genome insta-
bility in PARPi-treated BRCA1/53BP1-deficient cells (Figure 1C)
(Bothmer et al., 2011). Surprisingly, despite rescuing CSR, the
53BP18A allele failed to promote genome instability in PARPi-
treated BRCA1/53BP1-deficient cells above the levels observed
in controls (Figure 1C). This effect was not due to differences
in the expression levels of 53BP1 (Figure 1D) or in the recruitment
of 53BP1 and RIF1 to DSBs (Figure 1E). Similar to B cells,
BRCA1/53BP1-deficient MEFs complemented with 53BP1DB
were hypersensitive to PARPi, whereas 53BP18A transduced
MEFswere not (Figure S1 available online). Thus, themechanism
by which 53BP1 promotes CSR and blocks HR in BRCA1-
deficient cells is distinct. Moreover, the recruitment of RIF1 is
insufficient to induce genome instability in PARPi-treated
BRCA1-deficient cells.
Role of PTIP in the DNA Damage Response
Upon DNA damage, PTIP binds to the serine 25 residue within
the N terminus of 53BP1(Munoz et al., 2007), which is located
within the eight N-terminal sites mutated in 53BP18A. Consistent
with this, immunoprecipitation analysis revealed that PTIP
association with 53BP1 after irradiation was abrogated in cells
expressing S25A-harboring mutants 53BP18A, 53BP115A, or
53BP128A (Figures 2A and S2A). In contrast, the damage-
induced 53BP1/PTIP interaction was maintained in the
53BP17A mutant, comprising alanine substitutions of 7 S/TQ
phosphorylation sites C terminus of those mutated in 53BP18A
(Figures 1A and S2A).
To explore the function of PTIP in the DDR, we asked whether
PTIP-deficient cells are sensitive to DNA damaging agents that
are predominantly repaired by HR (Sonoda et al., 2006). WT
and PTIP/MEFs were exposed to either cisplatin, camptothe-
cin, or PARPi, all of which sensitize HR-deficient cells (Bryant
et al., 2005; Farmer et al., 2005). Each of these agents induced
a similar level of chromosomal aberrations and reduction in cell
survival in WT and PTIP/ MEFs (Figures 2B, 2C, and S2B). In
contrast, PTIP/MEFs were sensitive to irradiation (IR) (Figures
2B, 2C, and S2B) (Gong et al., 2009; Jowsey et al., 2004; Munoz
et al., 2007). Moreover, 53BP18A MEFs exhibited increased
genome instability and reduced cell survival following IR (Figures
S2C and S2D). To examine the recruitment of HR proteins to
DSBs, we evaluated BRCA1, RAD51, and g-H2AX foci formation
after IR in WT and PTIP/ MEFs. All of these factors were nor-
mally recruited to DSBs in PTIP-deficient cells (Figure S2E).
Moreover, 53BP1 also formed robust foci in the absence of
PTIP (Figure S2E). Thus, PTIP/ MEFs are tolerant to agents
that are highly toxic to HR-deficient cells and the recruitment
of several factors implicated in DSB repair is intact in the
absence of PTIP. Nevertheless, both PTIP/ and 53BP18A
MEFs are sensitive to IR.
PTIP Is Dispensable for NHEJ during CSR but Is
Required for NHEJ of Dysfunctional Telomeres
To explore the role of PTIP in NHEJ, we first assayed CSR. Dele-
tion of PTIP in B cells leads to a defect in class switching to IgG3,
IgG2b, and IgG1 (Daniel et al., 2010; Schwab et al., 2011). By re-
cruiting an MLL-like methyltransferase complex to the switch re-
gions of these isotypes, PTIP promotes histone modificationsCell 153, 1266–1280, June 6, 2013 ª2013 Elsevier Inc. 1267
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and transcription initiation of IgG3/IgG2b/IgG1 germline switch
regions, which are necessary for AID targeting (Daniel et al.,
2010; Schwab et al., 2011). However, PTIP does not affect tran-
scription at Igm and Igε (Daniel et al., 2010), indicating that PTIP-
associated methyltransferase complex promotes the accessi-
bility of some but not all switch loci. To distinguish between
PTIP’s effects on transcription versus DSB repair, we compared
CSR to IgG1 and IgE on day 5 after stimulation with aCD40+IL4
as described (Wesemann et al., 2011). As expected PTIPf/f
CD19CRE (PTIP/) B cells displayed a defect in switching to
IgG1 (Figures 3A and 3B), which is consistent with decreased
Igg1 germline transcription (Daniel et al., 2010; Schwab et al.,
2011). However, there was no defect in IgE germline transcrip-
tion (Daniel et al., 2010) or IgE CSR in PTIP-deficient cells (Fig-
ures 3A and 3B). Indeed, IgE CSR was consistently higher in
the absence of PTIP, likely because Sg1 is no longer a target
for AID. In contrast to PTIP/, ablation of RIF1 inRif1f/fCD19CRE
(RIF1/) B cells impaired CSR to both IgG1 and IgE (Figures 3A
and 3B). We conclude that loss of PTIP phenocopies the
53BP18A mutant allele in that neither has a significant impact
on NHEJ during CSR.
An alternative end-joining pathway can catalyze substantial
CSR end-joining to IgG1 and IgE even in the absence of classical
NHEJ (Boboila et al., 2010). Loss of PTIP leads to IR sensitivity
but tolerance to agents that are repaired by HR. We therefore
speculated that PTIP might function in other reactions besides
CSR that might rely on classical NHEJ, such as the fusion of
dysfunctional telomeres. When the shelterin factor TRF2 is
removed, deprotected telomeres trigger ATM-dependent phos-
phorylation of 53BP1, and the ends are processed by NHEJ to
generate chromosome fusions (Celli et al., 2006; Rai et al.,
2010; Zimmermann et al., 2013). Because ATM-dependent
phosphorylation of 53BP1 is also required for interaction be-
tween 53BP1 and PTIP (Figures 2A and S2A) (Jowsey et al.,
2004; Manke et al., 2003), we asked whether PTIP promotes
NHEJ-mediated fusion of deprotected telomeres. To address
this, we uncapped telomeres in SV40-immortalized WT and
PTIP/ MEFs by removing TRF2 with short hairpin RNA against
TRF2 (Rai et al., 2010). Upon TRF2 depletion we observed a
similar level of phosphorylation of the ATM target KAP-1 in WT
and PTIP/ MEFs, as measured by quantitative flow cytometry
(Figure 4A). Consistent with this, there was an accumulation of
cytologically discernable telomere-induced DNA damage foci
(TIFs) containing g-H2AX in WT and PTIP/ cells (Figure 4B).
Despite a robust DNA damage response and activation ofFigure 1. Characterization of a Separation of Function Mutant 53BP1
(A) Diagram of the 53BP1 retroviral constructs used. Hash marks indicate locatio
(B) Top: Representative flow cytometry plots measuring CSR after stimulation
53BP1DB (amino acids 1–1710), the N-terminal mutant 53BP18A or empty vector (E
marker. Bottom: Dot plot indicating IgG1 CSR as a percentage ofWT value in the s
tailed unpaired t test); BRCA1/53BP1+DB versus BRCA1/53BP1+8A, p > 0.1, w
(C) BRCA1/53BP1/ B cells were reconstituted with empty vector, 53BP1DB
sentative images of aberrant chromosomes. Dot plot indicates the total aberrat
analyzed for each genotype in each experiment. **p < 0.01 (two-tailed unpaired
(D) Western blot analysis of 53BP1 expression in WT B cells and BRCA1/53BP
(E)BRCA1/53BP1/B cells infected with EV, 53BP1DB or 53BP18A retroviruses
bottom). Cells were counterstained with DAPI (blue). Scale bar, 10 mm.
See also Figure S1.ATM, the frequency of end-end chromosomal fusions was
reduced by 2.8-fold in PTIP/ MEFs relative to WT (Figures
4C and 4D). Whereas 42% of WT cells bearing fusions had
more than 30% of their chromosome ends fused, only 13%
of PTIP KO cells had greater than 30% of their ends fused
(Figure 4E). Thus, PTIP deficiency results in a reduction in the
number of long-chain telomere fusions when telomeres are de-
protected. We conclude that PTIP contributes to the NHEJ of
dysfunctional telomeres.
PTIP Promotes Genome Instability in BRCA1-Deficient
Cells
In contrast to 53BP1, loss of RIF1 only partially reverses the
chromosomal aberrations and hypersensitivity produced
by PARPi treatment of BRCA1-deficient cells (Escribano-Dı´az
et al., 2013; Zimmermann et al., 2013). To determine
whether PTIP could overcome the HR defects in BRCA1-defi-
cient cells, we crossed PTIPf/f and BRCA1f(D11)/f(D11) mice with
CD19 CRE transgenic mice to simultaneously delete PTIP and
exon 11 of BRCA1 in primary B lymphocytes. When unchal-
lenged, BRCA1+/+PTIP+/+ CD19CRE (WT), BRCA1f(D11)/f(D11)
CD19CRE (BRCA1/), PTIPf/f CD19CRE (PTIP/), and
BRCA1f(D11)/f(D11)PTIPf/f CD19CRE (BRCA1/PTIP/) doubly
deficient B cells divided normally as determined by carboxyfluor-
escein succinimidyl ester (CFSE) dye dilution (Figure 5A) and
cell-cycle distribution (Figure 5B). Treatment with PARPi did
not impair the proliferation of WT or PTIP/B cells (see also Fig-
ures 2B and 2C); however, BRCA1/ cells underwent fewer di-
visions over the course of 72 hr (Figure 5A). In contrast, loss of
PTIP completely reversed the BRCA1/ growth defect (Fig-
ure 5A). Strikingly, although PARPi treatment generated chro-
matid breaks, chromosome breaks, and radial chromosomes
in BRCA1-deficient cells (Bunting et al., 2010), BRCA1/
PTIP/ B cells were insensitive to PARPi (Figure 5C). Thus,
ablation of PTIP phenocopies both the 53BP18A mutation (Fig-
ure 1C) and 53BP1 deficiency (Bouwman et al., 2010; Bunting
et al., 2010; Cao et al., 2009) in that it promotes genome stability
and survival in BRCA1 mutant cells.
Loss of PTIP Increases HR in BRCA1 Mutant Cells by
Promoting DSB Resection
BRCA1 and RAD51 function in a common HR pathway that pro-
motes RAD51-mediated DNA strand exchange (Bhattacharyya
et al., 2000; Moynahan et al., 1999; Scully et al., 1997).
Loss of 53BP1 rescues RAD51 foci formation and HR inn of substituted S/TQ sites.
of WT and BRCA1/53BP1/ B cells infected with retroviruses expressing
V). Numbers represent the percentages of IgG1 switched cells. B220 is a B cell
ame experiment. Three independent experiments are shown. **p < 0.001 (two-
hich is not significant (ns).
and 53BP18A retroviruses and treated with PARPi. The arrows indicate repre-
ions per cell in three independent experiments. At least 50 metaphases were
t test); ns: not significant.
1/ B cells stimulated and infected with empty vector, 53BP1DB, or 53BP18A.
were assayed for IRIF (10 Gy, 2 hr recovery) for RIF1 (red, top), and 53BP1 (red,
Cell 153, 1266–1280, June 6, 2013 ª2013 Elsevier Inc. 1269
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BRCA1-deficient cells (Bouwman et al., 2010; Bunting et al.,
2010). To explore whether PTIP deficiency also promotes HR
in BRCA1-deficient cells, we irradiated WT, BRCA1/, PTIP/,
and BRCA1/PTIP/B cells and measured the frequency of
immunofluorescent RAD51 foci. All mutant cells proliferated
similarly to WT over the course of 3 days (Figure 5A), and as ex-
pected, RAD51 foci were reduced in IR-treated BRCA1/ cells
(Figure 5D). However, in PTIP/ cells, the frequency of RAD51
foci was greater than WT, and RAD51 foci were normalized to
WT levels in BRCA1/PTIP/ B cells (Figure 5D). These results
suggest that loss of PTIP reverses the HR defect in BRCA1-defi-
cient cells, thereby explaining the insensitivity of BRCA1/
PTIP/ B cells to PARPi.
Loss of PTIP might promote RAD51 foci formation by allowing
increased resection of DSBs; this is similar to what happens
with the loss of 53BP1 (Bunting et al., 2010; Difilippantonio
et al., 2008). Because 50/30 DSB end resection produces
RPA-coated single-strand DNA, we monitored RPA foci forma-
tion by high content microscopy. Irradiated PTIP/ cells ex-
hibited a significant increase in the mean number of RPA foci
per cell relative to WT (Figure 5E); moreover, the fraction of
PTIP/ cells that had more than 15 RPA foci following IR was
approximately 2-fold greater than WT (Figure 5E). Thus, PTIP
limits the amount of chromatin bound RPA at IR-induced DSBs.
PTIP Recruitment to DSBs Promotes Radial
Chromosomes in BRCA1-Deficient Cells
PTIP is a subunit of the MLL3/4 methyltransferase complex and
promotes histone H3 lysine 4 trimethylation and transcription
initiation at specific promoters, such as the Sg3/Sg1 switch
regions of the Igh locus (Daniel et al., 2010) (Figure S3A). To
determine whether transcription of DDR genes is altered by
PTIP ablation, we profiled the transcriptome of WT and PTIP/
B cells. Overall, there were 471 RefSeq annotated genes that
were deregulated by more than 5-fold in PTIP/ versus WT
(Figure S3B). However, HR and NHEJ DNA damage response
genes were not among deregulated pathways (Figures S3B
and S3C). This suggests that the functions of PTIP in sup-
pressing HR might be unrelated to its role in transcriptional
regulation.
To determine whether PTIP recruitment to DSBs is essential
for its effects on HR, we made use of a point mutation in the
BRCT domain 3 (W663R) of PTIP that selectively blocks its inter-
action with 53BP1 (Gong et al., 2009; Munoz et al., 2007) and
is unable to form foci (Figure S4A) (Daniel et al., 2010) but
retains PTIP association with the MLL3/4 complex, which isFigure 2. Response of PTIP to Different DNA Damaging Agents
(A) 53BP1/ B cells were reconstituted with empty vector, 53BP1DB, 53BP18A, o
45 min recovery) and immunoprecipitation was performed with anti-FLAG antib
immunoprecipitated protein (right).
(B) Isogenic immortalizedWT andPTIP/MEFswere either untreated or treatedw
PARP inhibitor (PARPi, 1 mM) and chromosomal aberrations (chromatid breaks
spreads for each genotype and each treatment. Data from an independent expe
(C) WT (green lines) and PTIP/ (blue line) MEFs were treated with different dose
formed in untreated cells from the same genotype. An experiment performed in pa
(red line).
See also Figure S2.dependent on BRCT (domains 5 and 6) (Patel et al., 2007).
BRCA1/ PTIP/ B cells were infected with PTIPWT and
PTIPW663R encoding retroviruses, treated with PARPi, and moni-
tored for chromosomal damage (Figures 5F and S4B). Whereas
PTIPWT expression in BRCA1/PTIP/ cells led to an increase
in the number of chromosomal radials relative to uninfected
cells, BRCA1/PTIP/ cells transduced with PTIPW663R re-
mained insensitive (Figures 5F and S4B). Thus, PTIP recruitment
to DSBs is necessary to block HR in BRCA1-deficient cells.
Recruitment of PTIP to DSBs Is Dependent on the Eight
Most N-Terminal S/TQ Phosphorylation Sites of 53BP1
To explore the mechanism of PTIP recruitment to DSBs, we
expressed FLAG-tagged PTIP in WT, 53BP1/, and ATM/
MEFs and irradiated them with 10 Gy (Figure 6A). Although
PTIP ionizing-irradiation-induced foci (IRIF) were detectable in
nearly all WT cells, PTIP IRIF formation was impaired in the
absence of 53BP1 or ATM (Figure 6A). Measurements of coloc-
alization coefficients of g-H2AX (a marker of the DNA breaks)
with PTIP in irradiated WT, 53BP1/, and ATM/ MEFs re-
vealed that 80% of g-H2AX foci in WT cells contained PTIP,
whereas less than 15% and 10% of g-H2AX foci in the
53BP1/ and ATM/ cells, respectively, contained PTIP.
Consistent with these findings, PTIP IRIF was highly sensitive
to pharmacological inhibition of ATM (ATMi), less sensitive to
ATRi treatment, and insensitive to DNA-PKi. (Figure S5). These
findings contrast with previous reports suggesting that PTIP,
53BP1, and ATM are independently recruited to DSBs (Gong
et al., 2009; Jowsey et al., 2004; Munoz et al., 2007). Because
available PTIP antibodies are unable to detect endogenous
PTIP foci, we used laser microirradiation to generate DSBs in
WT, 53BP1/, and ATM/ MEFs. In WT cells, PTIP was re-
cruited to laser scissors-induced DSBs, which colocalized with
g-H2AX (Figure 6B). Consistent with our analysis of IRIF, PTIP
recruitment to DNA damage sites was 53BP1 and ATM depen-
dent (Figure 6B). Moreover, PTIP failed to be recruited to DSBs
in 53BP1/ MEFs reconstituted with a mutant protein lacking
all 28 N-terminal S/TQ phosphorylation sites of 53BP1,
53BP128A (Figure 6B). We conclude that ATM-dependent phos-
phorylation of 53BP1 is necessary for PTIP recruitment to DSBs.
Given that RIF1 is also recruited to DSBs in a 53BP1- and
ATM-dependent manner (Chapman et al., 2013; Di Virgilio
et al., 2013; Escribano-Dı´az et al., 2013; Feng et al., 2013; Silver-
man et al., 2004; Zimmermann et al., 2013), we next monitored
the codependency of PTIP and RIF1 for localization to DNA dam-
age foci (Figure 6C). We found that 82% of PTIP IRIF colocalizedr 53BP128A retroviruses that were FLAG-tagged. Cells were irradiated (10 Gy,
odies. Western blot analysis of PTIP and FLAG are shown for input (left) and
ith irradiation (IR, 2 Gy), cisplatin (CisPt, 0.5 mM), camptothecin (CPT, 10 nM) or
, chromosome breaks, and radials) were quantified in at least 50 metaphase
riment is shown in Figure S2B.
s of the above drugs, and colony formation was quantified relative to colonies
rallel demonstrated that 1 mMPARPi treatment is toxic for BRCA1mutantMEFs
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Figure 3. PTIP Is Dispensable for CSR to IgE
PTIPf/fCD19CRE (PTIP/), (Rif1f/fCD19CRE)
RIF1/ and littermate WT B cells were stimulated
with aCD40 plus IL-4 and analyzed for IgG1 and
IgE CSR on day 5.
(A) Representative flow cytometry plots. The per-
centages of IgG1 switched cells (upper-left quad-
rant) and IgE switched cells (lower-right quadrant)
is indicated.
(B) Dot plot indicates IgG1 and IgE CSR in PTIP/
and RIF1/ as a percentage of theWT value in the
same experiment. **p < 0.01 (two-tailed unpaired
t test); ns: not significant.with RIF1 foci and 78% of RIF1 colocalized with PTIP foci (Fig-
ure 6C, n > 800 foci). However, RIF1 was recruited to DNA dam-
age sites in PTIP/MEFs (Figure 6D) and vice versa (Figure 6E).
Thus, RIF1 and PTIP are independently recruited to IRIF in a
phospho-53BP1-dependent manner.
To further define the residues required for recruitment to
phospho-53BP1, we examined PTIP and RIF1 recruitment in
53BP1DB, 53BP18A, and 53BP17A mutant MEFs (Figures 2A and1272 Cell 153, 1266–1280, June 6, 2013 ª2013 Elsevier Inc.S2A). Whereas expression of 53BP1DB in
53BP1/ MEFs reconstituted PTIP IRIF
(Figures 7A and S6A), PTIP recruitment to
DSBs was abrogated in 53BP18A MEFs
(Figures 7A and S6A). By contrast, RIF1
recruitment was independent of these
eight most N terminus phosphorylation
sites on 53BP1, partially dependent on
the seven S/TQ phosphorylation sites C
terminus to 53BP18A, and abrogated in
53BP115A mutant cells that lack all 8S/TQ
and 7S/TQ phosphorylation sites (Figures
7A–7C and S6B). Thus, PTIP and RIF1
exhibit distinct phosphorylation-depen-
dent interactions with 53BP1 that guide
them to DSBs. The association of PTIP
with the 8S/TQ sites on 53BP1 upon DNA
damage (Figures 2A, 7, and S6A) likely ex-
plains why loss of PTIP phenocopies
53BP18A with respect to CSR, irradiation
sensitivity, and reversal of genome insta-
bility in BRCA1-deficient cells.
DISCUSSION
Regulation of DSB Repair Choice
53BP1 and BRCA1 play a critical role in
channeling DSBs into either NHEJ or
HR. 53BP1 promotes NHEJ in G1 by teth-
ering DSBs together and by protecting
these ends from exonuclease processing
(Bothmer et al., 2010; Difilippantonio
et al., 2008). In S phase, the inhibitory ef-
fect of 53BP1 on resection is antagonized
by BRCA1 (Bouwman et al., 2010; Bun-
ting et al., 2010). Loss of BRCA1 resultsin a shift toward a mutagenic NHEJ pathway that results in chro-
mosomal abnormalities, tumorigenesis, and embryonic lethality,
but all of these phenotypes are relieved by 53BP1 deletion
(Bouwman et al., 2010; Bunting et al., 2010; Cao et al., 2009).
In contrast, loss of classical NHEJ proteins (e.g., Ku, Ligase IV,
DNA-PKcs) does not overcome the HR defects associated
with BRCA1 deficiency (Bunting et al., 2012; Bunting et al.,
2010), perhaps because these factors play a more limited role
in repressing 50-30 resection (Bunting et al., 2012; Sfeir and de
Lange, 2012). Despite the striking rescue of BRCA1 deficiency,
disrupting 53BP1 does not reverse the DNA repair defects asso-
ciated with downstream mediators of the HR reaction (e.g.,
XRCC2, BRCA2, or PALB2) (Bouwman et al., 2010; Bowman-
Colin et al., 2013; Bunting et al., 2010). Thus, 53BP1 and
BRCA1 oppose each other during critical initial stages of DSB
repair before commitment to repair the ends by NHEJ or HR.
Mechanism of PTIP and RIF1 Association with 53BP1
The molecular events that are required for 53BP1 to promote the
ligation of DNA ends during CSR and the aberrant chromosomal
rearrangements in BRCA1 mutant cells were previously thought
to be identical. Surprisingly our data suggest that the pro-NHEJ
and anti-HR functions of 53BP1 are in fact distinct and separable
activities that nevertheless require 53BP1 phosphorylation.
These complementary aspects of 53BP1’s activities are medi-
ated by the independent recruitment of RIF1 and PTIP, respec-
tively, to phosphorylated 53BP1.
PTIP contains BRCT domains that interact directly with phos-
phorylated 53BP1 (Manke et al., 2003; Munoz et al., 2007). In
contrast, RIF1 does not contain a known phosphorecognition
motif, and it remains unclear how ATM-dependent phosphoryla-
tion facilitates RIF1 association with 53BP1. RIF1 may associate
with 53BP1 directly or through interactions with effector mole-
cules that contain BRCT phosphobinding modules (Figure 7D).
Based on the observation that there is no detectable defect in
RIF1 foci in 53BP18A cells (Figures 7A and S6B), we suspected
that a major RIF1-interaction motif would reside C terminus of
the 8S/TQ PTIP interaction sites. Consistent with this, the
53BP17A C-terminal mutant exhibits a reduction in RIF1 IRIF
(Figures 7A–7C) and CSR (Bothmer et al., 2011). RIF1 IRIF and
CSR are further reduced in 53BP115A mutant cells that lack
8S/TQ and 7S/TQ sites (Figures 7A and 7B) (Bothmer et al.,
2011), suggesting that both regions contribute to RIF1 interac-
tions with 53BP1 (Figure 7D). If so, we would predict some de-
gree of competition between PTIP and RIF1 binding to 53BP1.
Consistent with this, we have found an increased association
between PTIP and 53BP1 in response to DNA damage in
RIF1-deficient cells (Figure S6C). Thus, distinct from PTIP,
RIF1 association with 53BP1 occurs via multidomain interac-
tions (Figure 7D).
Role of PTIP and RIF1 in DSB Resection
Deletion of either PTIP or RIF1 leads to increased resection (Fig-
ure 5E) (Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-
Dı´az et al., 2013; Feng et al., 2013; Zimmermann et al., 2013).
However, whereas PTIP ablation rescues HR in BRCA1-deficient
cells and is largely dispensable for NHEJ during CSR, RIF1 is
essential for CSR and only partially contributes to the HR defects
in BRCA1-deficient cells (Di Virgilio et al., 2013; Escribano-Dı´az
et al., 2013; Feng et al., 2013; Zimmermann et al., 2013). How
can these observations be reconciled? One possibility is that
distinct S/TQ kinase target sites in 53BP1 are phosphorylated
during CSR in G1 and during replication fork collapse in S, result-
ing in independent recruitment of the two factors to DNA ends in
distinct phases of the cell cycle. Consistent with this idea, it was
reported that the localization of RIF1 to DSBs is mainly restrictedto G1 and is suppressed by BRCA1 in S/G2 (Chapman et al.,
2013; Escribano-Dı´az et al., 2013; Feng et al., 2013). However,
our finding that PTIP and RIF1 colocalize in the majority of irradi-
ated cells and that both proteins form IRIF during G1 and S/G2
(Figure S7) indicates that PTIP and RIF1 are not recruited to
DSBs in distinct cell-cycle phases.
Another possibility is that PTIP and RIF1 sites on 53BP1 are
equally phosphorylated during the cell cycle but that these pro-
teins might make the DSB-proximal chromatin refractory to a
distinct set of nucleases. For example, initial DNA end resection
is mediated by MRE11/RAD50/NBS1 and CTIP, whereas DNA2,
EXO1, and BLM carry out more extensive resection (Symington
andGautier, 2011), andRIF1 appears to be involved in protection
against initial but not sustained resection (Feng et al., 2013). In
this model, the level of resection supported by loss of RIF1would
be insufficient for complete rescue of HR in BRCA1-deficient
cells, which might require more extensive 30 single-strand tails.
In contrast, ablation of PTIP supports the sustained resection
required for the rescue of HR in BRCA1-deficient cells. Thus,
RIF1 and PTIP may block different steps in resection or distinct
nucleases that mediate HR.
Role of PTIP and RIF1 in Telomeric End-Joining
Depending on the nature of the break, RIF1 and PTIP might
cooperate to promote NHEJ. For example, PTIP and RIF1 defi-
ciency both result in IR sensitivity (Figures 2B and 2C) (Feng
et al., 2013), and defective NHEJ of dysfunctional telomeres (Fig-
ure 4) (Chapman et al., 2013; Zimmermann et al., 2013). It has
been demonstrated that 53BP1 has RIF1-independent roles in
promoting telomeric end-joining, evidenced by the considerably
higher frequency of telomeric fusions in RIF1/TRF2/ versus
53BP1/TRF2/ or 53BP128ATRF2/ MEFs (Lottersberger
et al., 2013; Zimmermann et al., 2013). This RIF1-independent
but phospho-53BP1-dependent function at telomeres has
been linked to the induction of chromosome mobility (Zimmer-
mann et al., 2013), which increases the probability that DNA
ends fuse. Because PTIP binds to DSBs in a 53BP1-dependent
but RIF1-independent manner, it is possible that this 53BP1-
dependent/RIF1-independent increase in telomere mobility is
mediated by PTIP.
Implications for Cancer Therapy
The identification of separation of function mutations that
selectively disrupt antirecombination functions of 53BP1 during
replication fork collapse and CSR may open up new therapeutic
opportunities. Breast cancers arising in BRCA1mutation carriers
frequently show low levels of 53BP1 expression (Bouwman et al.,
2010), whichmight result in resistance to PARPi therapy, a prom-
ising strategy for treating HR-deficient tumors (Bryant et al.,
2005; Farmer et al., 2005). Consistent with this, 53BP1 was
lost in a fraction of BRCA1-deficient mouse mammary tumors
that acquired PARPi resistance in vivo (Jaspers et al., 2013).
Interestingly, a fraction of PARPi-resistant tumors restored HR
yet did not lose 53BP1. We speculate that PTIP mutation might
emerge as a novel causal factor in PARPi resistance of
BRCA1-deficient mammary tumors that restore HR. With
respect to intervention, our study also suggests that it might
be possible to increase HR in BRCA1 heterozygous carriersCell 153, 1266–1280, June 6, 2013 ª2013 Elsevier Inc. 1273
Figure 4. PTIP Is Required for NHEJ of Dysfunctional Telomeres
(A) WT and PTIP/MEFs were infected with a retrovirus expressing either an empty vector or shRNA against TRF2 (shTRF2), and phosphorylated KAP1 (pKAP1)
levels were measured by flow cytometry.
(B) g-H2AX (green) in telomere-dysfunction-induced foci (TIF) generated in shTRF2-infected WT cells. PNA probe is shown in red, and images are merged on top
of DAPI (blue). Scale bar, 10 mm.
(C) Representative images of a metaphase spread from WT and PTIP/ MEFs infected with shTRF2. Telomere fusions are visualized by a telomeric PNA probe
(red) and DAPI (blue). Arrows point to representative telomeric fusions.
(legend continued on next page)
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Figure 5. Ablation of PTIP Rescues Homol-
ogous Recombination in BRCA1-Deficient
Cells
(A) WT, BRCA1/, PTIP/, and BRCA1/
PTIP/ B cells were pulsed with CFSE and stim-
ulated with (red) or without (green) PARPi. CFSE
signal diminishes with increasing division.
BRCA1/ cells are sensitive to PARPi (arrow in-
dicates sluggish cells) but loss of PTIP in BRCA1-
deficient cells rescues the proliferation defect.
(B) WT, BRCA1/, PTIP/, and BRCA1/
PTIP/ B cells were stimulated with LPS+IL4 and
cell-cycle distribution was monitored by propidum
iodide (PI) staining. Percentage of cells in G1, S,
and G2/M is indicated.
(C) Analysis of genomic instability (radial chromo-
somes, chromatid breaks, and chromosome
breaks) in metaphases from B cells treated with
1 mM PARPi. At least 50 metaphases were
analyzed for each genotype.
(D) B cells were stimulated for 2 days, irradiated
with 10 Gy, and the percentage of cells with
immunofluorescent RAD51 foci were quantified (at
least 400 cells counted for each genotype).
Data in (B) and (C) represent mean of three ex-
periments ± standard deviations. **p < 0.05 (two-
tailed unpaired t test), ns, not significant.
(E) High-throughput microscopy quantification of
RPA foci per cell in WT and PTIP/ MEFs that
were either untreated or treated with 30 Gy IR.
Top: representative image of chromatin bound
RPA in irradiated WT and PTIP/ cells. Bottom:
quantitation of RPA foci. Bar indicates the mean
number of RPA foci per cell, and the blue box
designates cells with more than 15 foci, whose
percentage is indicated above each box. **p <
0.001.
(F) BRCA1/PTIP/ B cells were reconstituted
with PTIPWT or PTIPW663R retroviruses (expressing
a GFP marker driven by an internal ribosome entry
site) and treated with PARPi. Cells were sorted
(GFPpositive = infected and GFPnegative = unin-
fected) and metaphases were analyzed for radial
chromosomes (n = 50 metaphases analyzed in
each case).
See also Figures S3 and S4.without compromising B cell immunoglobulin class switching by
inhibiting the recruitment of PTIP to DSBs.EXPERIMENTAL PROCEDURES
Mice, MEFs, B Cell Culture, and Infections
53BP1/ (Ward et al., 2004), BRCA1f(D11)/f(D11) (NCI mouse repository), RIF1f/f
(Buonomo et al., 2009; Di Virgilio et al., 2013), and PTIPf/f (Daniel et al., 2010)(D) Quantitation of telomeric fusion frequencies. At least 1,800 chromosomes fro
experiments. **p < 0.01 (two-tailed unpaired t test). Error bars represent SEM.
(E) Distribution of telomeric fusions per metaphase in WT and PTIP/ MEFs.
p(chi-square) < 1 3 105. Error bars represent SEM.mice have been described. Resting splenic B cells were isolated from 8- to
12-week-old WT or mutant spleen with anti-CD43 microbeads (anti-Ly48;
Miltenyi Biotech) and were cultured with LPS (25 mg/ml; Sigma) and IL-4
(5 ng/ml; Sigma) or aCD40 (1 mg/ml; eBiosciences) and IL4 as described
(Barlow et al., 2013; Wesemann et al., 2011). WT, 53BP1/, and ATM/
MEFs were immortalized by SV40. SV40T immortalized PTIPf/f (Cho et al.,
2009) and RIF1f/f MEFs were infected with CRE viruses to delete PTIP and
RIF1, respectively. PMX-PIE-based retroviruses encoding 53BP1DB and
53BP18A were previously described (Bothmer et al., 2011). Coding sequencesm each genotype were analyzed. Mean value derived from three independent
At least 30 cells were examined in each of three independent experiments.
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Figure 6. Recruitment of PTIP to DSBs Is ATM and Phospho-53BP1-Dependent but RIF1-Independent
(A) WT, 53BP1/, and ATM/ MEFs were infected with a FLAG-tagged WT PTIP retrovirus. Cells were irradiated with 10 Gy, and FLAG (red) IRIF together with
g-H2AX (green) were assessed 4 hr post-IR. DAPI is indicated in blue.
(B) WT, 53BP1/, ATM/, and 53BP1/MEFs reconstituted with 53BP128A were treated with Hoecsht 33342 and then irradiated with a 364 nm laser line. Cells
were allowed to recover for 15 min before processing for immunfluorescence analysis of PTIP and g-H2AX. Hoechst counterstain is indicated in blue.
(C) Cells expressing GFP-PTIPwere irradiatedwith 10Gy, and PTIPGFP (green) and RIF1 (red) IRIF were assessed 4 hr later. A representative image is shown; 82%
of PTIP IRIF colocalized with RIF1 foci and 78% of RIF1 colocalized with PTIP foci (nR 800 foci examined; cells had on average 28 foci).
(D) RIF1 IRIF (red) in irradiated WT and PTIP/ MEFs.
(E) RIF1 (red) and PTIP (red) recruitment to laser scissors damage in WT and RIF1/ MEFs. Damaged cells are indicated by g-H2AX tracks (green). Scale
bars, 10 mm.
See also Figure S5.
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Figure 7. PTIP and RIF1 Association with DSBs Is Dependent on Distinct Phosphorylation Sites on 53BP1
(A) 53BP1/ MEFs (reconstituted with 53BP1DB, 53BP18A, 53BP17A, or 53BP115A) were costained with RIF1 (red) and PTIP (green).
(B) Quantitation of percent 53BP1DB, 53BP18A, 53BP17A, or 53BP115A cells with greater than ten 53BP1, PTIP, or RIF1 foci. At least 100 cells were analyzed for
each genotype.
(C) Integrated intensity of individual RIF1 IRIF in 53BP1/MEFs reconstituted with DB or 7A. Average RIF1 foci intensity (red line) is 1.6-fold greater in DB versus
7A (**p < 0.001, one-tailed unpaired t test), and a greater percentage of very intense foci (z score > 3) are generated in 53BP1DB compared to 53BP17A (blue box).
(D) Model for regulation of 53BP1 pro-NHEJ and anti-HR activities by distinct phosphointeractions with RIF1 and PTIP, respectively. PTIP binds to the 8S/TQ
sites. RIF1 recruitment is largely dependent on C-terminal 7S/TQ sites, but RIF1 may also be stabilized by interactions with 8S/TQ. An unknown factor (X) may
bind directly to phosphorylated 53BP1 and mediate RIF1 recruitment, whereas PTIP interaction with 53BP1 is direct (Munoz et al., 2007).
See also Figures S6 and S7.
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for mouse PTIPWT/PTIPW663R and PTIP-GFP were cloned into the PMX-IRES-
GFP and MIG-IRES-mCherry retroviral vectors, respectively. PARP
(KU58948), ATM (Ku55933), and DNA-PK (NU7026) inhibitors were obtained
from Astra Zeneca and ATRi has recently been described (Toledo et al., 2011).
Flow Cytometry, Metaphase Analysis, and Telomere FISH
For FACs analysis, splenic B cells were stained with fluorochrome-conjugated
anti-B220, anti-igG1, and anti-igE antibodies (PharMingen) as described
(Wesemann et al., 2011). Carboxyfluorescein succinimidyl esther (CFSE)
labeling was performed to track cell division. Samples were acquired on a
FACSCalibur (Becton Dickinson), and cell sorting was preformed on a
FACsAria (Becton Dickinson). Cells were harvested for metaphase analysis
as described (Calle´n et al., 2007a). The murine TRF2 shRNA-targeting
construct and MEF retroviral infection have been described (Rai et al., 2010).
Telomere-induced foci were visualized by hybrization with anti-mouse
g-H2AX antibody (Upstate Biotechnology) together with PNA probe (Applied
Biosystems). Phosphorylated Kap-1 was detected by flow cytometry after
intracellular staining using the BD Cytofix/Cytoperm kit (BD Biosciences).
DNA Damage, Laser Microirradiation, Immunoprecipitation,
and RNA-Sequencing
Cells were treated with different DNA damaging agents (IR, CPT, CisPt, and
PARPi), and colony survival was assessed after 14 days, or metaphase anal-
ysis was performed 24 hr after treatment. For immunofluorescent staining,
cells were irradiated with indicated doses of ionizing radiation, allowed to
recover, and then fixed and processed as described (Celeste et al., 2003).
For microirradiation, cells were presensitized in DMEM media containing
0.1 mg/ml of Hoechst 33342 for 60 min before replacing with phenol red free
media containing 5 mM HEPES, and then irradiated with the 364 nm laser
line on a LSM510 confocal microscope (Zeiss) equipped with a heated stage.
Cells were allowed to recover for 15min prior to processing for immunofluores-
cence. Analysis of RPA foci was performed using an Opera High-Content
Screening system as described (Lo´pez-Contreras et al., 2012). Primary anti-
bodies for immunofluorescence were rabbit anti-53BP1 (Novus), mouse
anti-g-H2AX (Upstate Biotechnology), mouse or rabbit anti-FLAG-M2 (Sigma),
mouse anti-AIM1 (Becton Dickinson), mouse anti-GFP (Roche), rabbit anti-
RAD51 (Santa Cruz), rat anti-RPA (Cell Signaling), rabbit-anti-PTIP (Cho
et al., 2009), and rabbit-anti-RIF1(Di Virgilio et al., 2013). DNA was counter-
stained with DAPI. For immunoprecipitation, primary 53BP1/Bcells were in-
fected with retroviral constructs. Ninety-six hours postactivation, cells were
irradiated (10 Gy), left to recover for 45 min, and collected by centrifugation.
Cells were lysed, sonicated, and cell lysates were incubated with magnetic
beads (M-270 epoxy beads, Invitrogen) conjugated with anti-FlagM2 antibody
(Di Virgilio et al., 2013). 53BP1-associated proteins were eluted by incubation
in NuPAGE LDS sample buffer (Invitrogen) supplemented with 45 mM DTT
for 10 min at 72C. For RNA sequencing, reads from each cDNA library were
mapped onto the Build 37 assembly of the National Center for Biotechnology
Informationmouse genome data (July 2007; NCBI37/mm9) using TopHat. Bio-
conductor (Gentleman et al., 2004) was used to calculate the RPKM (reads per
kilobase exon model per million mapped reads) of the RefSeq annotated
genes.
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